Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
123I-EGF internalisation in tu...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction
Bibliographic Details
Main Authors:
Cornelissen, B
,
Remaut, K
,
Kersemans, V
,
Oltenfreiter, R
,
Burvenich, I
,
Slegers, G
Format:
Conference item
Published:
2004
Holdings
Description
Similar Items
Staff View
Similar Items
123I-EGF uptake in tumours predicts long-term farnesyltransferase therapy outcome in athymic mice
by: Cornelissen, B, et al.
Published: (2004)
Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.
by: Cornelissen, B, et al.
Published: (2005)
Radiosynthesis and in vivo evaluation of 123I-rTIMP-2 as potential SPECT tumour imaging agent
by: Oltenfreiter, R, et al.
Published: (2004)
In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy.
by: Cornelissen, B, et al.
Published: (2005)
A rapid in vivo diagnostical assay to assess the effect of a farnesyl transferase inhibitor on lovo cells using I-123-hEGF
by: Cornelissen, B, et al.
Published: (2003)